Shylaja Mani1, Nandita Khera2, Lisa Rybicki3, Naimisha Marneni4, Hetty Carraway4, Halle Moore4, Helen Whited2, Navneet S Majhail5. 1. Department of Hematology and Oncology, Ohio State University, Columbus, OH. 2. Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ. 3. Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH. 4. Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH. 5. Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH. Electronic address: majhain@ccf.org.
Abstract
BACKGROUND: Primary care physicians (PCPs) may face barriers to caring for hematologic malignancy and hematopoietic cell transplantation (HCT) survivors. METHODS: A Web-based survey consisting of 40 questions and 2 case scenarios was administered to 302 PCPs at 2 large integrated health care systems. The questionnaire assessed perceived barriers to delivery of care to hematologic malignancy/HCT survivors, resources available to care for cancer survivors, practices for care coordination with hematologist-oncologists, and preferred models of care delivery. RESULTS: Overall response rate was 30% (n = 86). PCPs reported several barriers such as lack of resources to facilitate care (69%), lack of awareness of screening/prevention guidelines (55%) and psychosocial needs of survivors (65%), inadequate time (65%), and patient preference to follow up with their oncologists (66%). They expressed confidence in caring for general medical issues (84%) and general cancer screening (73%), but they preferred that oncologists manage cancer-related medical issues (42%) as well as screen for cancer recurrence (52%) and secondary cancers (55%). In multivariable analysis, PCPs who had previously cared for a large number of hematologic malignancy/HCT survivors and those with a longer time since graduation from medical school had greater confidence in managing cancer-related medical issues. CONCLUSION: PCPs report several barriers in providing care to hematologic malignancy/HCT survivors. Clinical experience with this patient population is associated with greater confidence in providing survivorship care. Several barriers identified by PCPs in providing survivorship care to hematologic malignancy/HCT survivors are potentially addressable by education and clinical decision support tools and guidelines, thereby enhancing the patients' clinical experience and care coordination with hematologist-oncologists.
BACKGROUND: Primary care physicians (PCPs) may face barriers to caring for hematologic malignancy and hematopoietic cell transplantation (HCT) survivors. METHODS: A Web-based survey consisting of 40 questions and 2 case scenarios was administered to 302 PCPs at 2 large integrated health care systems. The questionnaire assessed perceived barriers to delivery of care to hematologic malignancy/HCT survivors, resources available to care for cancer survivors, practices for care coordination with hematologist-oncologists, and preferred models of care delivery. RESULTS: Overall response rate was 30% (n = 86). PCPs reported several barriers such as lack of resources to facilitate care (69%), lack of awareness of screening/prevention guidelines (55%) and psychosocial needs of survivors (65%), inadequate time (65%), and patient preference to follow up with their oncologists (66%). They expressed confidence in caring for general medical issues (84%) and general cancer screening (73%), but they preferred that oncologists manage cancer-related medical issues (42%) as well as screen for cancer recurrence (52%) and secondary cancers (55%). In multivariable analysis, PCPs who had previously cared for a large number of hematologic malignancy/HCT survivors and those with a longer time since graduation from medical school had greater confidence in managing cancer-related medical issues. CONCLUSION: PCPs report several barriers in providing care to hematologic malignancy/HCT survivors. Clinical experience with this patient population is associated with greater confidence in providing survivorship care. Several barriers identified by PCPs in providing survivorship care to hematologic malignancy/HCT survivors are potentially addressable by education and clinical decision support tools and guidelines, thereby enhancing the patients' clinical experience and care coordination with hematologist-oncologists.
Authors: Navneet S Majhail; Li Tao; Christopher Bredeson; Stella Davies; Jason Dehn; James L Gajewski; Theresa Hahn; Ann Jakubowski; Steven Joffe; Hillard M Lazarus; Susan K Parsons; Kim Robien; Stephanie J Lee; Karen M Kuntz Journal: Biol Blood Marrow Transplant Date: 2013-07-30 Impact factor: 5.742
Authors: Theresa Hahn; Philip L McCarthy; Anna Hassebroek; Christopher Bredeson; James L Gajewski; Gregory A Hale; Luis M Isola; Hillard M Lazarus; Stephanie J Lee; Charles F Lemaistre; Fausto Loberiza; Richard T Maziarz; J Douglas Rizzo; Steven Joffe; Susan Parsons; Navneet S Majhail Journal: J Clin Oncol Date: 2013-05-28 Impact factor: 44.544
Authors: Michael T Halpern; Meera Viswanathan; Tammeka S Evans; Sarah A Birken; Ethan Basch; Deborah K Mayer Journal: J Oncol Pract Date: 2014-09-09 Impact factor: 3.840
Authors: Sadhna M Shankar; Andrea Carter; Can-Lan Sun; Liton Francisco; K Scott Baker; James G Gurney; Daniel G Weisdorf; Stephen J Forman; Leslie L Robison; Marcia Grant; Smita Bhatia Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-04 Impact factor: 4.254
Authors: Ellen M Denzen; Jaime M Preussler; Elizabeth A Murphy; K Scott Baker; Linda J Burns; Jackie Foster; Lensa Idossa; Heather K Moore; Tammy J Payton; Darlene Haven; Balkrishna Jahagirdar; Naynesh Kamani; J Douglas Rizzo; Lizette Salazar; Barry A Schatz; Karen L Syrjala; John R Wingard; Navneet S Majhail Journal: Biol Blood Marrow Transplant Date: 2018-10-10 Impact factor: 5.742
Authors: G Juliusson; J Abrahamsson; V Lazarevic; P Antunovic; Å Derolf; H Garelius; S Lehmann; K Myhr-Eriksson; L Möllgård; B Uggla; A Wahlin; L Wennström; M Höglund Journal: Leukemia Date: 2016-10-31 Impact factor: 11.528
Authors: Navneet S Majhail; Elizabeth Murphy; Purushottam Laud; Jaime M Preussler; Ellen M Denzen; Beatrice Abetti; Alexia Adams; RaeAnne Besser; Linda J Burns; Jan Cerny; Rebecca Drexler; Theresa Hahn; Lensa Idossa; Balkrishna Jahagirdar; Naynesh Kamani; Alison Loren; Deborah Mattila; Joseph McGuirk; Heather Moore; Jana Reynolds; Wael Saber; Lizette Salazar; Barry Schatz; Patrick Stiff; John R Wingard; Karen L Syrjala; K Scott Baker Journal: Haematologica Date: 2018-12-04 Impact factor: 9.941
Authors: Claire Snyder; Youngjee Choi; Katherine C Smith; Renee F Wilson; Christina T Yuan; Paul C Nathan; Allen Zhang; Karen A Robinson Journal: JNCI Cancer Spectr Date: 2022-03-02
Authors: Jennifer Berano Teh; Farah Abdulla; Kelly Peng; Liezl Atencio; Meagan Echevarria; Aleksi Iukuridze; Alan C Geller; F Lennie Wong; Stephen J Forman; Ryotaro Nakamura; Badri Modi; Saro H Armenian Journal: J Invest Dermatol Date: 2021-02-18 Impact factor: 7.590
Authors: Anne Nicolaisen; Gitte Bruun Lauridsen; Peter Haastrup; Dorte Gilså Hansen; Dorte Ejg Jarbøl Journal: Scand J Prim Health Care Date: 2022-03-07 Impact factor: 3.147